Abstract:Background: As a main drug for diseased thrombus, some clinically used thrombolytic agents have various disadvantages, safer novel thrombolytic agents are of great demand. This study aimed to achieve high and efficient production of a fibrinolytic enzyme with superior enzymatic properties, by a combination strategy of codon optimization, gene dosage and process optimization in Komagataella phaffii (K. phaffii). Results: After codon optimization, the fibase from a marine Bacillus subtilis was expressed and secreted in K. phaffii GS115. Recombinant strains harboring different copies of the fib gene (fib-nc) were successfully obtained via Geneticin (0.25-4 mg/ml) screening on minimal dextrose selection plates and assessment via real-time quantitative PCR. The respective levels of fibase produced by strains expressing fib-5.4c, fib-6c, fib-8c, fib-9c, and fib-12c were 4428, 5781, 7323, 7930, and 2472 U/ml. Levels increased as the copy number increased from 4 to 9, but decreased dramatically at copy number 12. After high cell density fermentation optimization, the highest fibase activity of the strain expressing fib-9c was 7930 U/ml in a shake flask and increased to 12,690 U/ml after 3 days of continuous culture in a 5-L fermenter, which is one of the highest levels of production reported. The recombinant fibase was maximally active at pH 9.0 and 45 °C, and was remarkably stable at pH levels ranging from 5 to 10 and temperatures up to 50 °C. As a metal-dependent serine protease, fibase did not cause hemolysis in vitro and preferentially degraded fibrin directly. Conclusions: The combination of codon optimization, gene dosage, and process optimization described herein could be used for the expression of other therapeutic proteins difficult to express. The characteristics of the recombinant fibase suggest that it has potential applications for thrombosis prevention and therapy.

Enhancing Activity of Fibrinolytic Enzyme-Producing Strain by Protoplast Fusion of Inactivated Parents

Enhanced cellulase production of the Trichoderma viride mutated by microwave and ultraviolet.

Cloning and Expression of One Fibrinolytic Enzyme from Bacillus Sp. Zlw-2

Screening the Fusarium Graminearum Inhibitory Mutant Strain from Bacillus Subtilis by Atmospheric-Pressure Plasma Jet

Study on Protoplasts Fusion of Mildiomycin-Producing Strains

Studies on the Fermentation Condition Optimization of Fibrinolytic Enzyme Produced by Armiilaria Luteo-virens Sacc

Protoplast Electrofusion Between Klebsiella Oxytoca and Bacillus Subtilis

An effective combination of codon optimization, gene dosage, and process optimization for high-level production of fibrinolytic enzyme in Komagataella phaffii (Pichia pastoris)

Protoplast preparation of Trichoderma taxi ZJUF0986 and screening of resistant mutants

Construction of an alkaline protease overproducer strain based on Bacillus licheniformis 2709 using an integrative approach

Identification of Protoplast Fusion Strain Fhhh by Randomly Amplified Polymorphic Dna

[Breeding, Optimized Fermentation and Enzymatic Properties of a Bacillus Licheniformis Mutant Producing Cyclomaltodextrin Glucanotransferase].

Strain improvement for enhanced production of cellulase in Trichoderma viride

Improving Effectiveness on Synthetic Medicine Wastewater Biotreatment with an Engineered Strain by Protoplast Fusion Between Bacterium and Fungus

Fermentation of starch for enhanced alkaline protease production by constructing an alkalophilic Bacillus pumilus strain

Isolation and Optimal Fermentation Conditions of Bacillus licheniformis SFD-Y5 for a New Douchi Fibrinolytic Enzyme Producer

A novel approach for improving the yield of Bacillus subtilis transglutaminase in heterologous strains

Genetic Analysis of Protoplast Fusant Xhhh Constructed for Pharmaceutical Wastewater Treatment.

Enhancement of fungichromin production of Streptomyces sp. WP-1 by genetic engineering

Crystal structure of bis[1-(4-bromobenzyl)pyridinium] bis(1,2-dicyanoethene-1,2-dithiolato-κ2 S,S′)nickelate(II)